Medicalsystem Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Medicalsystem Biotechnology has a total shareholder equity of CN¥2.9B and total debt of CN¥41.5M, which brings its debt-to-equity ratio to 1.4%. Its total assets and total liabilities are CN¥3.6B and CN¥682.8M respectively. Medicalsystem Biotechnology's EBIT is CN¥198.6M making its interest coverage ratio -12.3. It has cash and short-term investments of CN¥852.7M.
Key information
1.4%
Debt to equity ratio
CN¥41.54m
Debt
| Interest coverage ratio | -12.3x |
| Cash | CN¥852.74m |
| Equity | CN¥2.88b |
| Total liabilities | CN¥682.79m |
| Total assets | CN¥3.56b |
Recent financial health updates
No updates
Recent updates
Medicalsystem Biotechnology's (SZSE:300439) Solid Earnings May Rest On Weak Foundations
Nov 01
There's No Escaping Medicalsystem Biotechnology Co., Ltd's (SZSE:300439) Muted Earnings Despite A 39% Share Price Rise
Oct 08We Think That There Are Some Issues For Medicalsystem Biotechnology (SZSE:300439) Beyond Its Promising Earnings
Apr 30Financial Position Analysis
Short Term Liabilities: 300439's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥585.4M).
Long Term Liabilities: 300439's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥97.4M).
Debt to Equity History and Analysis
Debt Level: 300439 has more cash than its total debt.
Reducing Debt: 300439's debt to equity ratio has reduced from 72.8% to 1.4% over the past 5 years.
Debt Coverage: 300439's debt is well covered by operating cash flow (887.7%).
Interest Coverage: 300439 earns more interest than it pays, so coverage of interest payments is not a concern.